Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cancer Drug resistance Topoisomerases

Anti-Topoisomerase I antibody (ab3825)

Price and availability

288 134 ₸

Availability

Order now and get it on Thursday February 25, 2021

Anti-Topoisomerase I antibody (ab3825)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to Topoisomerase I
  • Suitable for: WB, ICC
  • Reacts with: Human
  • Isotype: IgG

You may also be interested in

TPEN, Metal ion chelator (ab141111)
Etoposide, Topoisomerase II inhibitor (ab120227)
Product image
Human TOP1MT knockout HEK-293T cell lysate (ab263395)
Product image
Alexa Fluor® 488 Anti-Topoisomerase I antibody [EPR5375] (ab197505)

Overview

  • Product name

    Anti-Topoisomerase I antibody
    See all Topoisomerase I primary antibodies
  • Description

    Rabbit polyclonal to Topoisomerase I
  • Host species

    Rabbit
  • Tested applications

    Suitable for: WB, ICCmore details
  • Species reactivity

    Reacts with: Human
  • Immunogen

    Recombinant fragment corresponding to Human Topoisomerase I aa 401-600.

  • General notes

    This product can be used as part of an assay for sumoylation activity. Human Aos 1 + Uba 2 (ab3804), Ubc 9 (ab3803) and Sumo 1 (ab3801) can be used to promote in vitro sumoylation of a sumoylation marker (human Topoisomerase I protein fragment) (ab3828). The reaction products can be detected using our Sumo 1 (ab3819 and ab3824) and Topoisomerase I (ab3825) antibodies. Sumoylation assays are carried out in a final volume of 20µl in reaction conditions (20 mM Hepes pH 7.5, 5mM MgCl2, 2mM ATP). This antibody is equivalent to the antibody used in our Sumoylation Control kits. Sumoylation Protocol: 1. Prepare a suitable purified substrate protein. (For the control, use 2µl Topoisomerase I marker for each reaction.) 2. In each reaction, add 4µl E2 to substrate first, then 2µl Sumo 1, 2µl 10x reaction buffer, 2µl E1. Finally, add H2O to bring up to 20µl. We would recommend adding fresh 2mM ATP to be sure that sufficient energy is supplied. 3. The best reaction concentration of proteins is as following: Aos 1 + Uba 2: 7.5µg/ml. Ubc 9: 50µg/ml. SUMO 1: 50µg/ml. For the control assay we recommend running the assay at 37ºC for 30-60 minutes. 4. Detect the reaction products by Western blot using a suitable antibody. For the control reaction use 1/1000 dilution of the supplied Topoisomerase I antibody. Four sumoylated bands should be seen on the gel for the control reaction. This assay has been shown to work with crude extracts. Be aware that Uba 2 contains his-rich regions which might cross-react with antibodies against the 6x-His epitope tag. During western analysis with anti-6x-His antibodies, Uba 2 at 80 kDa might be shown.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer

    Constituent: 100% PBS
  • Concentration information loading...
  • Purity

    Whole antiserum
  • Primary antibody notes

    This product can be used as part of an assay for sumoylation activity. Human Aos 1 + Uba 2 (ab3804), Ubc 9 (ab3803) and Sumo 1 (ab3801) can be used to promote in vitro sumoylation of a sumoylation marker (human Topoisomerase I protein fragment) (ab3828). The reaction products can be detected using our Sumo 1 (ab3819 and ab3824) and Topoisomerase I (ab3825) antibodies. Sumoylation assays are carried out in a final volume of 20µl in reaction conditions (20 mM Hepes pH 7.5, 5mM MgCl2, 2mM ATP). This antibody is equivalent to the antibody used in our Sumoylation Control kits. Sumoylation Protocol: 1. Prepare a suitable purified substrate protein. (For the control, use 2µl Topoisomerase I marker for each reaction.) 2. In each reaction, add 4µl E2 to substrate first, then 2µl Sumo 1, 2µl 10x reaction buffer, 2µl E1. Finally, add H2O to bring up to 20µl. We would recommend adding fresh 2mM ATP to be sure that sufficient energy is supplied. 3. The best reaction concentration of proteins is as following: Aos 1 + Uba 2: 7.5µg/ml. Ubc 9: 50µg/ml. SUMO 1: 50µg/ml. For the control assay we recommend running the assay at 37ºC for 30-60 minutes. 4. Detect the reaction products by Western blot using a suitable antibody. For the control reaction use 1/1000 dilution of the supplied Topoisomerase I antibody. Four sumoylated bands should be seen on the gel for the control reaction. This assay has been shown to work with crude extracts. Be aware that Uba 2 contains his-rich regions which might cross-react with antibodies against the 6x-His epitope tag. During western analysis with anti-6x-His antibodies, Uba 2 at 80 kDa might be shown.
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Epigenetics and Nuclear Signaling
    • DNA / RNA
    • DNA Synthesis
    • Topoisomerases
    • Cancer
    • Drug resistance
    • Topoisomerases

Images

  • Immunocytochemistry - Anti-Topoisomerase I antibody (ab3825)
    Immunocytochemistry - Anti-Topoisomerase I antibody (ab3825) This image is courtesy of an anonymous Abreview

    ab3825 staining Topoisomerase I in human 293T cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with 0.5% Triton X-100 and blocked with 3% BSA for 1 hour at 22°C. Samples were incubated with primary antibody (1/100 in PBS + 1% BSA) for 1 hour at 22°C. An Alexa Fluor® 488-conjugated donkey anti-rabbit IgG polyclonal (1/1000) was used as the secondary antibody.

    See Abreview

  • Immunocytochemistry - Anti-Topoisomerase I antibody (ab3825)
    Immunocytochemistry - Anti-Topoisomerase I antibody (ab3825)
    blue: DAPI; green: Topo I. Hela cell staining.
  • Western blot - Anti-Topoisomerase I antibody (ab3825)
    Western blot - Anti-Topoisomerase I antibody (ab3825)

    Primary antibody incubated at a 1/1000 dilution for 60 minutes at 25ºC.

  • Western blot - Anti-Topoisomerase I antibody (ab3825)
    Western blot - Anti-Topoisomerase I antibody (ab3825)
    All lanes : Anti-Topoisomerase I antibody (ab3825) at 1/5000 dilution

    Lane 1 : SW210.5 human SCLC cell xenograft lysate.
    Lane 2 : 5M2 human NSCLC cell lysate (bicarb. buffer).
    Lane 3 : 5M2 human NSCLC cell lysate (M-Per buffer).
    Lane 4 : Normal human lung tissue lysate.
    Lane 5 : A431 cell (human epidermoid carcinoma) lysate .
    Lane 6 : Rh30 cell (human rhabdomyosarcoma) lysate.

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat anti rabbit heavy and light (HRP) at 1/25000 dilution

    Performed under reducing conditions.

    Predicted band size: 91 kDa



    This image is courtesy of an Abreview submitted by Mike Campa on 7 September 2005. We do not have any further information relating to this image.

    See Abreview

  • Western blot - Anti-Topoisomerase I antibody (ab3825)
    Western blot - Anti-Topoisomerase I antibody (ab3825) This image is courtesy of an anonymous Abreview
    All lanes : Anti-Topoisomerase I antibody (ab3825) at 1/200 dilution

    Lane 1 : K562 nuclear lysate
    Lane 2 : Mouse N2a whole cell lysate at 100 µg

    Secondary
    All lanes : Donkey anti-rabbit IgG HRP polyclonal at 1/1000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 91 kDa
    Observed band size: 100 kDa
    why is the actual band size different from the predicted?
    Additional bands at: 35 kDa (possible non-specific binding)


    Exposure time: 15 seconds

    See Abreview

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-Topoisomerase I antibody (ab3825)

  •  
  • Product image

    Anti-Topoisomerase I antibody [EPR5376(2)] (ab131166)

    Applications: ICC/IF, WB

  •  
  • Product image

    Alexa Fluor® 488 Anti-Topoisomerase I antibody [EPR5375] (ab197505)

    Applications: Flow Cyt, ICC/IF

  •  
  • Product image

    Anti-Topoisomerase I antibody [EPR5375] (ab109374)

    Applications: Flow Cyt, ICC/IF, IHC-P, WB

  •  
  • Product image

    Alexa Fluor® 647 Anti-Topoisomerase I antibody [EPR5375] (ab196930)

    Applications: Flow Cyt, ICC/IF

  •  
  • Product image

    Anti-Topoisomerase I antibody [EPR5375] - BSA and Azide free (ab219735)

    Applications: Flow Cyt, ICC/IF, IHC-P, WB

  •  
  • Product image

    Anti-Topoisomerase I antibody [EPR5376(2)] - BSA and Azide free (ab240047)

    Applications: ICC, WB

  •  
  • Product image

    HRP Anti-Topoisomerase I antibody [EPR5375] (ab196642)

    Applications: WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-SIRT1 antibody (ab12193)

  •  
  • Product image

    Anti-CROP antibody (ab231982)

  •  
  • Product image

    Anti-PICOT antibody (ab226396)

  •  
  • Product image

    Anti-RFP antibody (ab152123)

  •  
  • Product image

    Anti-FAM29A antibody (ab150806)

  •  
  • Product image

    Anti-PSMD7/Mov34 antibody (ab126263)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.